Ocera Therapeutics
contact us
  • home
  • about us
  • pipeline
  • therapeutic areas
  • clinical trials
  • partnering and licensing
  • news and events
  • Press Releases
  • Ocera in the News
  • Events
  • Publications

News and Events

Publications

 

AST-120
OCR-002

"AST-120 (spherical carbon adsorbent) Improves Pain and Bloating in a Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Non-Constipating Irritable Bowel Syndrome (IBS)", Tack, J, EASL, 2010
"Mild Hepatic Encephalopathy (HE) Assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is Highly Prevalent in Ambulatory Patients with Cirrhosis", Randolph, C, DDW 2010
'"The Efficacy and Tolerability of AST-120 (Spherical Carbon Adsorbent) in Active Pouchitis", Shen, Bo, AJG, 2009 (in press)
“A Pilot Study on the Efficacy and Tolerability of AST-120 in the Treatment of Active Pouchitis”, Shen, Bo, ACG, 2007 (Poster)
“The Efficacy and Tolerability of AST-120 (Spherical Carbon Adsorbent) in Active Pouchitis”, Shen, Bo, UEGW, 2008 (Poster)
“Absence of Interactions Between AST-120 (Spherical Carbon Adsorbent), a Novel Oral Adsorbent, and Concomitant Medications: Azathioprine and CiproXR®”, Willmer, Jonathan, UEGW (Poster) 
“Absence of Interactions Between AST-120 (Spherical Carbon Adsorbent), a Novel Oral Adsorbent, and Concomitant Medications: Azathioprine and CiproXR®”, Willmer, Jonathan, UEGW (Abstract)
“Prevention of GI Absorption of Bacterial Toxins: and In Vitro Evaluation of the Potential for Prophylactic Use of a Novel Oral Adsorbent (AST-120)”, Anderson, Keith, DDW, 2008 (Abstract)
“AST-120: A Novel, Engineered Carbon Microsphere Product fir Use in Chronic Inflammatory Bowel Disease and Liver Dysfunction”, Anderson, Keith, DDW, 2008 (Abstract)
“AST-120 (Spherical Carbon Adsorbent): A Novel, Engineered Carbon Microsphere Product for Use in Chronic Inflammatory Bowel Disease and Liver Function”, Anderson, Keith, DDW, 2008 (Poster)
“Prevention of GI Absorption of Bacterial Toxins: an In Vitro Evaluation on the Potential for Prophylactic Use of a Novel Oral Adsorbent (AST-120, Spherical Carbon Adsorbent)”, Anderson, Keith, DDW, 2008 (Poster)
“A Novel Oral Adsorbent, AST-120, Specifically and Irreversibly Binds Pro-Inflammatory Mediators of the Gut In Vitro and In Vivo”, Anderson, Keith, UEGW, 2008 (Abstract)
“L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure”, Ytrebø, Lars Marius, Hepatology, Vol. 50, No. 1, 2009
“L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats”, Nathan, Davies, Hepatology, Vol. 50, No. 1, 2009

 

 
Copyright © 2010 Ocera Therapeutics, Inc.